參考文獻(xiàn)/References:
[1] 張穎,張博,張治國(guó),等.從肝脾腎三臟探討絕經(jīng)后骨質(zhì)疏松癥的發(fā)病機(jī)理[J].中國(guó)中醫(yī)基礎(chǔ)醫(yī)學(xué)雜志,2012,18(1):36.
[2] Arron JR,Choi Y.Bone versus immune system[J].Nature,2000,408(6812):535-536.
[3] 胥少汀,葛寶豐,徐印坎.實(shí)用骨科學(xué)[M].4版.北京:人民軍醫(yī)出版社,2012:1517.
[4] 李冠慧,李燦東,李西海,等.雌激素調(diào)控絕經(jīng)后骨質(zhì)疏松癥骨吸收-骨形成耦聯(lián)失衡的機(jī)制[J].中醫(yī)正骨,2016,28(2):36-40.
[5] Onal M,Xiong JH,Chen XR,et al.Receptor activator of nuclear factor kappa B ligand(RANKL)protein expression by B lymphocytes contributes to ovariectomy-induced bone loss[J].Journal of Biological Chemistry,2012,287(35):29851-29860.
[6] Mori G,D'Amelio P,Faccio R,et al.Bone-Immune Cell Crosstalk:Bone Diseases[J].J Immunol Res,2015:108451.
[7] 徐玉善,江艷,李少遊,等.絕經(jīng)后骨質(zhì)疏松癥的T細(xì)胞亞群的變化及意義[J].昆明醫(yī)科大學(xué)學(xué)報(bào),2015,36(4):34-36.
[8] 陳燕清,張俊龍,郭蕾,等.腎氣丸對(duì)腎陽虛證大鼠模型T細(xì)胞亞群影響的實(shí)驗(yàn)研究[J].中國(guó)中醫(yī)急癥,2014,23(3):380-381.
[9] 陳江華,顧向明.骨質(zhì)疏松患者體液免疫相關(guān)指標(biāo)的變化[J].國(guó)際檢驗(yàn)醫(yī)學(xué)雜志,2012,33(17):2077-2078.
[10] 張立智,蔣垚.骨免疫學(xué)研究進(jìn)展[J].國(guó)際骨科學(xué)雜志,2009,30(4):218-220.
[11] 楊明園,李超,李明.細(xì)胞因子與絕經(jīng)后骨質(zhì)疏松癥關(guān)系的研究進(jìn)展[J].中國(guó)骨質(zhì)疏松雜志,2014,20(6):698-705.
[12] 易偉蓮,廖德權(quán),林柏云,等.絕經(jīng)后骨質(zhì)疏松癥患者性激素、細(xì)胞因子及骨代謝指標(biāo)的變化及關(guān)系[J].檢驗(yàn)醫(yī)學(xué),2012,27(4):296-298.
[13] 王峰,鄭陸.脂聯(lián)素、瘦素與運(yùn)動(dòng)及骨代謝的關(guān)系[J].中國(guó)骨質(zhì)疏松雜志,2016,22(2):221-227.
[14] 陳志強(qiáng),鄒云雯,閆軍.絕經(jīng)女性骨組織中瘦素對(duì)骨代謝指標(biāo)的影響及相關(guān)機(jī)制研究[J].中華骨科雜志,2015,35(10):997-1003.
[15] 柯賢柱,葛鵬,石芳.絕經(jīng)后骨質(zhì)疏松患者血清脂聯(lián)素與瘦素和炎性細(xì)胞因子的相關(guān)性研究[J].中華關(guān)節(jié)外科雜志:電子版,2012,6(3):47-49.
[16] Ginaldi L,De Martinis M,Ciccarelli F,et al.Increased levels of interleukin 31(IL-31)in osteoporosis[J].BMC Immunol,2015,16:60.
[17] Xie LH,Zhao YP,Chen K,et al.Bioinformatics analysis of genes expression profiles of postmenopausal osteoporosis with Kidney Yin deficiency[J].Chinese Journal of Clinical Rehabilitation,2011,15(15):2833-2837.
[18] 謝麗華,陳娟,許惠娟,等.絕經(jīng)后骨質(zhì)疏松癥腎陰虛證差異表達(dá)基因CLCF1蛋白表達(dá)研究[J].中國(guó)骨質(zhì)疏松雜志,2015,21(12):1425-1428.
[19] 陳娟,謝麗華,李生強(qiáng),等.lncRNA在絕經(jīng)后骨質(zhì)疏松癥腎陰虛證中的表達(dá)特征及調(diào)控網(wǎng)絡(luò)分析[J].中國(guó)骨質(zhì)疏松雜志,2015,21(5):553-559.
[20] 許惠娟,謝麗華,李生強(qiáng),等.絕經(jīng)后骨質(zhì)疏松癥腎陽虛證的關(guān)聯(lián)基因LTBP1mRNA的表達(dá)研究[J].中國(guó)骨質(zhì)疏松雜志,2014,20(5):476-480.
[21] Jin HS,Kim J,Park S,et al.Association of the I264T variant in the sulfide quinone reductase-like(SQRDL)gene with osteoporosis in Korean postmenopausal women[J].PLoS One,2015,10(8):e0135285.
相似文獻(xiàn)/References:
[1]李林軍.應(yīng)用膨脹式椎弓根螺釘內(nèi)固定治療合并骨質(zhì)疏松的
胸腰椎退行性疾病[J].中醫(yī)正骨,2015,27(08):49.
[2]李學(xué)朋,朱立國(guó).骨疏康膠囊對(duì)去卵巢大鼠骨小梁的影響[J].中醫(yī)正骨,2015,27(12):12.
LI Xuepeng,ZHU Liguo.Effect of Gushukang Jiaonang(骨疏康膠囊)on bone trabecula in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(08):12.
[3]陳冠軍,陳揚(yáng),莊汝杰.可灌注骨水泥椎弓根螺釘系統(tǒng)
在老年腰椎疾患手術(shù)中的應(yīng)用[J].中醫(yī)正骨,2015,27(02):40.
[4]王丹輝,賁越,韓梅.林蛙油治療絕經(jīng)后骨質(zhì)疏松癥的臨床研究[J].中醫(yī)正骨,2014,26(01):27.
Wang Danhui*,Ben Yue,Han Mei..Clinical study of Rana temporaria oil in the treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(08):27.
[5]黃建華,黃建武,李慧輝,等.加味左歸丸對(duì)絕經(jīng)后骨質(zhì)疏松癥肝腎不足證
患者骨密度的影響[J].中醫(yī)正骨,2013,25(11):19.
Huang Jianhua*,Huang Jianwu,Li Huihui,et al.Effect of JIAWEI ZUOGUI pill on bone mineral density in postmenopausal osteoporosis patients with deficiency of liver and kidney[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(08):19.
[6]項(xiàng)旻,楊虹,林愛菊,等.絕經(jīng)后2型糖尿病患者骨質(zhì)疏松與血微量元素的關(guān)系研究[J].中醫(yī)正骨,2013,25(12):20.
Xiang Min*,Yang Hong,Lin Aiju,et al.Clinical study on the relationship between osteoporosis and serum trace elements levels in postmenopausal women with type 2 diabetes[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(08):20.
[7]史曉林,李春雯,張志強(qiáng).弱陽離子磁珠分離技術(shù)和基質(zhì)輔助激光解吸電離飛行時(shí)間質(zhì)譜技術(shù)在原發(fā)性Ⅰ型骨質(zhì)疏松癥血清標(biāo)志蛋白篩選中的應(yīng)用[J].中醫(yī)正骨,2014,26(03):5.
Shi Xiaolin*,Li Chunwen,Zhang Zhiqiang..Application of magnetic beads based weak cation exchange separation technology and matrix-assisted laser desorption-ionization time of flight mass spectrometry technology in screening serum protein markers of primary type-Ⅰ osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(08):5.
[8]李明,徐明雄,馮左基,等.自擬壯骨方治療絕經(jīng)后骨質(zhì)疏松癥的療效及作用機(jī)制研究[J].中醫(yī)正骨,2014,26(09):21.
Li Ming*,Xu Mingxiong,Feng Zuoji,et al.Study on the curative effect and mechanism of action of self-made ZHUANGGU decoction in treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(08):21.
[9]陳俊杰,李晴晴,夏瑢.脂代謝及血清內(nèi)脂素水平與絕經(jīng)后骨質(zhì)疏松癥的
相關(guān)性研究[J].中醫(yī)正骨,2012,24(04):16.
CHEN Jun-jie*,LI Qing-qing,XIA Rong.*.Study on the correlations between the levels of lipid metabolism and serum visfatin and postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(08):16.
[10]許超,肖魯偉,吳承亮.絕經(jīng)后女性骨質(zhì)疏松癥辨證分型與抑郁焦慮的關(guān)系研究[J].中醫(yī)正骨,2011,23(12):3.
XU Chao*,XIAO Lu-wei,WU Cheng-liang.*.Study on the relationship between the syndrome differ classification and the depression and anxiety for the postmenopausal women with osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2011,23(08):3.
[11]韓艷,溫利平,劉娜,等.補(bǔ)腎活血方對(duì)去卵巢大鼠骨代謝及骨密度的影響[J].中醫(yī)正骨,2015,27(12):7.
HAN Yan,WEN Liping,LIU Na,et al.Effect of Bushen Huoxue Fang(補(bǔ)腎活血方)on bone metabolism and bone mineral density in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(08):7.
[12]施振宇,劉鐘,陳文亮,等.中醫(yī)綜合療法防治絕經(jīng)后骨量減少的多中心臨床研究[J].中醫(yī)正骨,2017,29(04):1.
SHI Zhenyu,LIU Zhong,CHEN Wenliang,et al.A multicenter clinical study of complex therapy of traditional Chinese medicine for prevention and treatment of postmenopausal osteopenia[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(08):1.
[13]梁文娜,李西海,李燦東.血清microRNA與絕經(jīng)后骨質(zhì)疏松癥腎虛證的關(guān)系[J].中醫(yī)正骨,2017,29(10):53.
[14]梁文娜,李西海,胡柳,等.二至丸抑制絕經(jīng)后骨質(zhì)疏松大鼠骨代謝紊亂的作用機(jī)制研究[J].中醫(yī)正骨,2017,29(11):1.
LIANG Wenna,LI Xihai,HU Liu,et al.Study on mechanism of action of Erzhi Wan(二至丸)in inhibiting bone metabolism disorder in rats with postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(08):1.
[15]劉晨,李興勇,姚興璋,等.絕經(jīng)后骨質(zhì)疏松癥的流行病學(xué)概況及發(fā)病機(jī)制研究進(jìn)展[J].中醫(yī)正骨,2018,30(03):52.
[16]楊依然,劉鐘,毛一凡,等.酪蛋白激酶-2相互作用蛋白1基于磷脂酰肌醇3-激酶/蛋白激酶B/哺乳動(dòng)物雷帕霉素靶蛋白通路參與絕經(jīng)后骨質(zhì)疏松癥發(fā)生發(fā)展過程中細(xì)胞自噬的機(jī)制[J].中醫(yī)正骨,2018,30(04):59.
[17]曹俊青,鄭劍南,張麟.右歸丸聯(lián)合阿侖膦酸鈉口服治療絕經(jīng)后骨質(zhì)疏松癥腎陽虛證的臨床研究[J].中醫(yī)正骨,2018,30(05):20.
CAO Junqing,ZHENG Jiannan,ZHANG Lin.A clinical study of oral application of Yougui Wan(右歸丸)and alendronate sodium for treatment of postmenopausal osteoporosis with kidney-yang deficiency syndrome[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(08):20.
[18]李中萬,徐紹俊,楊廣鋼,等.健腎方聯(lián)合碳酸鈣D3咀嚼片(Ⅱ)
治療絕經(jīng)后骨質(zhì)疏松癥腎陽虛證[J].中醫(yī)正骨,2018,30(08):11.
LI Zhongwan,XU Shaojun,YANG Guanggang,et al.Oral application of Jianshen Fang(健腎方)and calcium carbonate and Vitamin D3 chewable tablets(Ⅱ)for treatment of postmenopausal osteoporosis with kidney-yang deficiency syndrome[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(08):11.
[19]趙凡,劉全,吳連國(guó).口服強(qiáng)骨飲聯(lián)合碳酸鈣D3片治療絕經(jīng)后骨質(zhì)疏松癥的臨床研究[J].中醫(yī)正骨,2019,31(04):26.
ZHAO Fan,LIU Quan,WU Lianguo.Oral applications of Qianggu Yin(強(qiáng)骨飲)and calcium carbonate and Vitamin D3 tablets for treatment of postmenopausal osteoporosis:a clinical study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2019,31(08):26.
[20]史曉林,楊依然,劉鐘,等.基于蛋白質(zhì)組學(xué)方法分析絕經(jīng)后骨質(zhì)疏松癥全血差異蛋白[J].中醫(yī)正骨,2019,31(06):7.
SHI Xiaolin,YANG Yiran,LIU Zhong,et al.Analysis of proteins which are differentially expressed in whole blood of patients with postmenopausal osteoporosis using proteomics approach[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2019,31(08):7.